other dosage forms:
needed effects
methotrexate
active ingredient
rasuvo
unwanted side effects
medical attention
following side effects
taking methotrexate
check
doctor
methotrexate side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
vasculitisrare
pericarditis
pericardial effusion
pericardial tamponade
hypotension
thromboembolic events
arterial thrombosis
cerebral thrombosis
thrombophlebitis
deep vein thrombosis
retinal vein thrombosis
pulmonary embolism
myocardial ischemia frequency
cerebral edema
exanthema
erythema
itchinguncommon
urticaria
photosensitivity
depigmentation
hyperpigmentation of the skin
alopecia
increase of rheumatic nodules
painful lesions of psoriatic plaque
herpetiform eruption of the skin
stevens-johnson syndrome
toxic epidermal necrolysis
lyell
syndrome
increased pigmentary changes of nails
acne
petechiae
ecchymoses
erythema multiforme
cutaneous erythematous eruptions
furunculosis
telangiectasiafrequency
exfoliative dermatitis
skin necrosis
skin ulceration
folliculitis
hidradenitis
allergic vasculitis
inflammation
ulceration of the vaginavery
loss of libido
males
females
impotence
impaired menstruation
vaginal discharge
infertility
abortion
fetal death
fetal defects
gynecomastia
defective oogenesis
spermatogenesis
transient oligospermia
vaginal bleeding
anorexia
nausea
vomiting
abdominal pain
inflammation
ulcerations of the mucous membrane of mouth
throat
hours after administration
stomatitis
dyspepsia
dehydrationcommon
diarrhea
hours after administration
gi bleeding
ulcers
pancreatitisrare
gingivitis
enteritis
melena
malabsorption
hematemesis
toxic megacolonfrequency
glossitis
incidence
severity of acute side effects
dose
frequency of administration
reported adverse reactions
ulcerative stomatitis
leukopenia
nausea
abdominal distress
malaise
undue fatigue
chills
fever
dizziness
resistance
infection
dysuriarare
oliguria
anuria
azotemiavery
proteinuriafrequency
cystitis
hematuria
leukocytopenia
thrombocytopenia
anemiauncommon
pancytopenia
agranulocytosis
hematopoietic disordersrare
megaloblastic anemia
severe bone marrow depression
aplastic anemia
lymphadenopathy
lymphoproliferative disorders
eosinophilia
neutropenia frequency
hemorrhage
hematoma
myelosuppression
preexisting myelosuppression
low hematologic cell counts
contraindications
use of this drug
patients with rheumatoid arthritis
psoriasis
close monitoring of the cbc
profound count nadirs
therapy discontinuation
folate therapy
leucovorin rescue
treated patients
febrile
neutropenia until proven
cytopenia
patients with rheumatoid arthritis
ra
long-term therapy
risk factors
renal dysfunction
preexisting folate deficiency
mean
corpuscular volume value
age
concomitant use of other anti-folate medications
trimethoprim-sulfamethoxazole
hypoalbuminemia
concomitant infection
history of bone marrow injury
surgery
concurrent use of nsaids
probenecid
pancytopenia
patients with rheumatoid arthritis
bone marrow recovery
weeks after the withdrawal of mtx
increase in liver
related enzymes
alat
asat
alkaline phosphatase
bilirubin
ldh levels
month after cessation of therapyuncommon
development of liver fattening
fibrosis
cirrhosis
normal values of liver enzymes
drop of serum albuminrare
acute hepatitis
hepatotoxicity
reactivation of chronic hepatitis
acute liver degeneration
liver insufficiency
liver failure
liver atrophy
necrosis
methotrexate
acute elevations of liver function tests
elevated serum transaminases
patients with rheumatoid arthritis
ra
low-dose therapy
chronic hepatotoxicity
fibrosis
cirrhosis
incidence of liver fibrosis
cirrhosis in patients with ra
low doses
averages
meta-analysis
incidence of progression of liver disease
worsening of grade on the histologic classification of roenigk
patients with ra
psoriatic arthritis averages
gram of mtx
total dose
chronic hepatotoxicity
chronic use of higher doses
years
total doses of grams
patients
ethanol
chronic renal insufficiency
diabetes
following
guidelines for patients with non-oncologic conditions :-rrb- screen
patients
complete liver blood tests
transaminases
albumin
alkaline phosphatase
bilirubin
hepatitis b
c
serologic studies
experts
viral serology
patients with abnormal liver function tests
baseline serum creatinine
complete blood count
cbc
;-rrb- baseline liver biopsy if the patient
preexisting liver disease
abnormal baseline ast
aspartate aminotransferase
history of excessive alcohol consumption
drinks/day
chronic hepatitis b
c infection ;-rrb- monitor
hepatic enzymes
weeks
understanding
fibrosis/cirrhosis
discontinuing mtx if serum transaminase levels
baseline
guidelines
withholding mtx
weeks if significant abnormalities
;-rrb- liver biopsy
significant hepatic enzyme abnormalities
months
liver biopsy
monthly ast levels
upper limit of normal
serum albumin levels
setting
controlled disease ;-rrb- if liver biopsy
roenigk grade
iiia
mild fibrosis
mtx
monitoring
liver biopsy
roenigk grade iiib
moderate fibrosis
cirrhosis
mtx
discontinued ;-rrb- mtx
patients with significant liver abnormalities
liver biopsy
post-therapy biopsy
years
grams
cumulative dose
liver chemistries
pre-biopsy coagulation studies
withholding of aspirin
other nsaids
allergic vasculitis
severe allergic reactions
anaphylactic shock
disseminated herpes zoster
pneumocystis carinii pneumoniavery
immunosuppression
hypogammaglobulinemia
sepsis
opportunistic infections
cases
infections
cytomegalic virus
acute paronychiafrequency
nocardiosis
cryptococcus mycosis
disseminated herpes simplex
listeria meningitis
mycobacterium avium
intracellular pneumonia
systemic fungal infections
cryptococcosis
nocardiosis
aspergillosis
histoplasmosis
sepsis
resistance
infection
pneumocystis jiroveci
pneumonia
common infection
respiratory tract infection
cutaneous bacterial infections
pneumonia
reactivation of hepatitis b infection
worsening of hepatitis c infection
new
opportunistic infection
therapy with methotrexate
drug-induced immune suppression
infections during mtx therapy
patients during low-dose therapy
ra
patients
great risk after high-dose therapy
mtx
elective surgery
risk of infectious complications
limited data
use of low-dose mtx for patients with rheumatoid arthritis
decreased cd
naive cd t lymphocytes
weeks of therapy
methotrexate
patients with overt
laboratory evidence of immunodeficiency syndromes
immunization
methotrexate therapy
immunization with live virus vaccines
been reports
disseminated vaccinia infections after smallpox immunization in patients
receiving methotrexate therapy
osteoporosis
arthralgia
myalgiarare
stress fracture
pain
muscular asthenia
paresthesia of the extremitiesfrequency
osteoporosis
osteonecrosis
aseptic necrosis of the femoral head
soft tissue necrosis
abnormal tissue cell changes
arthralgia/myalgia
pain
headache
fatigue
drowsinessuncommon
vertigo
confusion
seizures
convulsion
encephalopathyvery
paresis
effect on speech
dysarthria
aphasia
myelopathy
changes in sense of taste
metallic taste
meningism
acute aseptic meningitis
impaired vision
visual disturbances
vision
conjunctivitis
retinopathy
transient blindness/loss of vision
periorbital edema
blepharitis
epiphora
photophobia
eye discomfort
frequency
lymphomas
leukemias
drug
fever
impaired wound healingfrequency
fetal death
fetal damage
abortion
tinnitus
chills
malaise
fatigue
inflammation
ulceration of the urinary bladder
hematuria
renal failure
elevated serum creatinine
urea level frequency
renal insufficiency
high doses
severe nephropathy
pulmonary complications
interstitial alveolitis pneumonitis
general illness
dry/nonproductive cough
shortness of breath
dyspnea
chest pain
fever
pulmonary fibrosisrare
pharyngitis
apnea
bronchial asthma
pneumocystis carinii pneumonia
chronic obstructive pulmonary disease
pleural effusionfrequency
acute pulmonary edema
pleurisy
hypoxia
respiratory failure
diabetes mellitus
hyperuricemia frequency
metabolic disorder
tumor lysis syndrome
mood alterations
insomnia
cognitive dysfunctionfrequency
psychosis
depression
confusion
irritability
side effects of rasuvo
fda
healthcare professional for medical advice
powder for solution
solution
black, tarry stools
blood in the urine
stools
bloody vomit
diarrhea
joint pain
reddening of the skin
sores in the mouth
lips
stomach pain
swelling of the feet
lower legs
back pain
blurred vision
confusion
convulsions (seizures)
cough or hoarseness
dark urine
dizziness
drowsiness
fever or chills
headache
side pain
difficult urination
red spots on the skin
shortness of breath
unusual bleeding
bruising
unusual tiredness
weakness
yellow eyes
skin
hair loss, temporary
loss of appetite
nausea or vomiting
acne
boils on skin
pale skin
skin rash
itching